Skip to content

The effect of preoperative oral carbohydrates on the incidence of postoperative delirium in elderly patients undergoing non-cardiac surgery

The effect of preoperative consumption of clear carbohydrate-containing liquids on the incidence of postoperative delirium in elderly patients undergoing non-cardiac surgery:A prospective?open-label?randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110195
Enrollment
Unknown
Registered
2025-10-10
Start date
2025-10-15
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Nil Per Os(NPO) after Midnight group:Conventional preoperative fasting with nil per os (NPO) after midnight
preoperative oral carbohydrate group:Ingestion of 400ml of a carbohydrate-rich clear liquid beverage 2 to 3 hours before surgery

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged 60 years and above; 2.ASA class I-III; 3.Scheduled for elective non-cardiac surgery;

Exclusion criteria

Exclusion criteria: 1.Patients with conditions that increase the risk of aspiration (including gastroesophageal reflux disease, hiatal hernia, Zenker's diverticulum, pyloric stenosis, achalasia, gastroparesis, gastrointestinal obstruction, obesity, and those using medications that delay gastric emptying; 2.Patients with diabetes mellitus or impaired glucose tolerance; 3.Patients with a history of psychiatric disorders or conditions requiring long-term psychotropic medication (e.g., dementia, schizophrenia) or a history of alcoholism; 4.Patients with a history of cerebrovascular events within the past 3 months, such as stroke or transient ischemic attack (TIA); 5.Patients with abnormal liver or renal function: ALT or AST > 2 times the upper limit of normal, or CrCl < 30 mL/min; 6.Patients with an ejection fraction (EF) < 30% on echocardiography; second-degree type 2 or third-degree atrioventricular block; or a history of active cardiac disease (e.g., acute myocardial infarction, unstable angina); 7.Patients who have participated in another clinical trial within 4 weeks prior to enrollment;

Design outcomes

Primary

MeasureTime frame
incidence of postoperative delirium;

Secondary

MeasureTime frame
The incidence of postoperative nausea and vomiting (PONV) within 24 hours and the utilization of antiemetic medications.;Plasma osmolality, hematocrit, and electrolyte levels (sodium, potassium, calcium, lactate) at 30 minutes before surgery.;The degree of thirst, hunger, nausea, headache, dizziness, and anxiety 30 minutes before surgery.;Time to first flatus and defecation, and length of postoperative hospital stay.;Parameters measured on the first postoperative day included inflammatory mediators (IL-6, CRP), fasting blood glucose, insulin levels, the postoperative insulin resistance index, and the incidence of;Duration, severity, and subtypes of postoperative delirium.;Quality of Recovery at 24 hours after surgery;

Countries

China

Contacts

Public ContactYan Luo

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

ly11087@rjh.com.cn+86 21 6437 0045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026